Category
Sorafenib
CAS Number
1431697-81-2
Molecular Formula
C₂₁H₁₆ClF₃N₄O₃
Molecular Weight
464.82 g/mol
Synonym

4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide ; 4-[4-[[[2-chloro-3-(trifluoromethyl)phenyl]carbamoyl]amino]phenoxy]-N-methylpyridine-2-carboxamide ; 

Keywords
Intermediates
Heterocycles
Impurities
Amines
Aromatics
Fine Chemicals
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Optimized for trace-level detection, our Sorafenib EP impurity H reference standard is a necessary component developed by expert R&D scientists at Manasa Life Sciences in Hyderabad, India, for identifying minute impurities in oncology formulations. This compound accurately reflects the official Sorafenib European Pharmacopoeia impurity H identifier, corresponding to CAS Number: 1431697-81-2, Molecular Formula: C₂₁H₁₆ClF₃N₄O₃, Molecular Weight: 464.82 g/mol, and Chemical Name: 4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide. Use this high-purity Sorafenib related substance H analytical standard to validate your custom limits and safeguard batch consistency using our advanced HPLC, LCMS, NMR, and IR analytical services. Our Sorafenib EP impurity H qualitative reference standard arrives ready for immediate laboratory reconstitution and instrument calibration. Buy Sorafenib impurity H R&D reference standard batches under strict GMP/GDP conditions to secure the robust, high-integrity data, certified CoAs, and MSDSs necessary for your upcoming global regulatory submissions.